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ABSTRACT 
ANTIMICROBIAL ACTIVITY OF SOME MEDICINAL PLANTS 
ENDEMIC TO NORTH AMERICA 
SEPTEMBER 1999 
SAIDA A. SAFIYEVA 
B. S., AZERBAIJAN STATE UNIVERSITY BAKU 
M. S., AZERBAIJAN STATE UNIVERSITY BAKU 
M. S., UNIVERSITY OF MASSACHUSETTS AMHERST 
Directed by: Professor Lyle E. Craker. 
Essential oils extracted from fresh and dried roots and herb of Echinacea 
purpurea (L.) Moench, E. pallida Nutt, and E. angustifolia DC, and fresh herb of 
Chenopodium amhrosioides L., were tested for antimicrobial activity against gram¬ 
positive Staphylococcus aureus (ATCC 25923) and Enterococcus faecalis (ATCC 
19433), gram-negative Escherichia coli (ATCC 25922) and Pseudomonas aeruginosa 
(ATCC 27853), and the yeast Candida albicans (ATCC 14053). Antimicrobial screening 
was done on essential oils, extracted by a simultaneous steam distillation-solvent 
extraction procedure, using a qualitative agar diffusion test. Essential oil of 
Chenopodium amhrosioides was active against Candida albicans only. Essential oils of 
Echinacea species were active against all microorganisms tested. Candida albicans was 
the microorganism, most inhibited by the essential oils. Gram-negative bacteria were less 
sensitive to the action of essential oils than gram-positive. Overall, essential oils 
extracted from dried roots and herb of Echinacea species had more antimicrobial activity 
than oils extracted from fresh roots and herb. Gram-positive Enterococcus faecalis was 
sensitive only to oils extracted from fresh roots and herb of Echinacea species. 
Keywords: essential oils. Echinacea, Chenopodium ambrosioides. 
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CHAPTER I 
INTRODUCTION 
Biologically active, secondary metabolites from higher plants represent an 
important source of drugs used in a natural unmodified form or as templates for the 
synthesis of analogues with improved pharmacological activity or reduced toxicity 
(Farnsworth, 1984; Kinghorn, 1994; Borris, 1996; Soejarto, 1996). With the emergence 
of microbes resistance to antibiotics during the last decade, the possibility of plant 
containing novel antimicrobial compounds for pharmaceutical use has emerged 
(Berkowitz,1995; Jacoby, 1984). In this respect, the tremendous chemical diversity of 
higher plants will need to be evaluated for antimicrobial activity. 
Various screening methods for evaluation of antimicrobial properties of plant 
extracts have been reported (Mitscher et al., 1972; Brantner and Grein, 1994). By using 
specific indicator organisms predictive of possible utility against human bacterial 
diseases, Mitscher and Raghav Rao (1984) were able to detect reproducible antimicrobial 
activity in one in five extracts from wide variety of plant genera. According to Tschesche 
(1971), after investigation of 139 different plant species, 83 percent showed antibiotic 
activity with 29 percent active against bacteria, 13 percent active against fungi, and 40 
percent active against both groups. Generally, flowers were the most active, with leaves, 
roots, and branches having less activity. 
In many plants producing biologically active secondary metabolites, the essential 
or volatile oil fraction exhibited the most antimicrobial activity (Deans, 1991). Essential 
oils are volatile lipophylic substances with a characteristic aroma, composed mostly of 
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terpenes and phenylpropenes (Waterman, 1993). Essential oils play an ecological role in 
a plant and generally store isolated from normal physiological processes of the producing 
plant in extracellular spaces such as glands or ducts (Deans and Waterman, 1993). 
The antimicrobial, antifungal and insecticidal properties of essential oils have 
been intensively investigated (Carta et al. 1996; Lis-Balchin et al. 1996; Deans and 
Ritchie, 1987; Safiyev et al., 1998; Duke, 1990; Mookherjee et al. 1993). Significant 
biological activity against wide range of bacteria, fungus, molds and yeast, as well as 
antioxidant and antiviral activities showed by essential oils, suggested their utilization in 
aromatherapy, pharmaceutical, cosmetic, and agricultural industries (Svoboda and 
Deans, 1995; Dorman et al. 1995; Bishop, 1995; Deans and Waterman, 1993). 
Various essential oils from aromatic plants are presently used as sedatives, 
expectorants, antiseptics, and disinfectants, in addition to use as flavoring agents in food 
industry and perfumery. Although the medical applications of essential oils are presently 
limited, essential oil producing medicinal plants are included in pharmacopoeias of many 
countries (Sticher,1977). 
The objective of the present study was to investigate antimicrobial activity 
proposed for essential oils of Echinacea species and Chenopodium ambrosioides against 
human pathogenic bacteria. 
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CHAPTER II 
LITERATURE REVIEW 
Plants are considered to be medicinal if pharmacological activity with possible 
therapeutic use exists. An effective method for the discovery of new drugs has been the 
screening of selected plant extracts, based on ethnomedical information or traditional 
medicinal uses, with subsequent identification and isolation of the active compounds 
(Duke, 1990; Cave, 1985). In fact, 74 percent of all plant-derived drugs in clinical use 
worldwide have been discovered through investigations of ethnomedical uses (Soejarto, 
1996). 
Although ethnobotanical research is widely recognized and has expanded greatly 
in recent years, only a few screenings of North American medicinal plants have ever been 
undertaken, leaving the medicinal properties of the vast majority of North American 
plants unknown (Foster, 1991; Tyler, 1996; McCutcheon et al, 1992). North American 
flora does contain a large number of medicinal plants used by the aboriginal people. 
Indeed, American Indian medicine was in use for thousands of years (Hutchens, 1991). 
Native Americans used almost 3, 000 of 31, 566 vascular species for the medicinal 
purposes. Plant families Asteraceae, Rosaceae, Apiaceae, Ranunculaceae and 
Lamiaceae were intensively utilized (Moerman, 1998). 
According to Gilmore (1913), Native Americans used Echinacea (purple 
coneflower) for more purposes than any other medicinal plant, applying juice from fresh 
roots as an antidote for snakebites and other poisonous conditions, and for headaches, 
toothaches, sore throats, septic conditions, inflammations, eczema, ulcers and colds 
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(Vogel, 1970; Kindscher, 1989). In the late 19th and early 20th century a tincture of 
Echinacea angustifolia was the most widely used plant drug in the United States. The 
drug was used internally for the prophylactic and treatment of mild to moderately severe 
colds, in tumorous and syphilitic conditions, influenza, and septic conditions, and 
externally for the treatment of hard to heal wounds and skin inflammations (Lloyd, 1917). 
Interest in Echinacea as a medicinal plant has recently increased, supported by the 
scientific justification of biological activity. 
Echinacea (Asteracea) contains nine species native to the United States and south 
central Canada and of these, three species are of medical importance (Fernald,1950; 
Foster, 1991) (Table 1). Echinacea species are also widely distributed as garden 
ornamentals with many cultivars developed for horticultural purposes (Foster, 1997). 
In the past decades, numerous chemical and pharmacological studies have been 
done on Echinacea species. The protective effects of caffeoyl derivatives of Echinacea 
species (echinacoside, chlorogenic acid, chicoric acid, cynarine, and caffeic acid) on the 
free radical-induced degradation of Type III collagen, indicate potential topical use of 
Echinacea extracts species for the prevention and treatment of photodamage to the skin 
(Facino et al, 1995). The phenolic compound echinacoside isolated from E. angustifolia 
roots has been reported to have wound healing activity (Stoll et al, 1950). A mixture of 
complex polysaccharides, named Echinacin B and isolated from E. angustifolia and E. 
purpurea, also appears to promote wound healing in experimental animals. Wound 
healing activity is attributed to the inhibition of hyaluronudase enzyme by the formation 
of a polysaccharide complex with hyaluronic acid that stimulates the growth of 
fibroblasts, the connective tissue forming cells (Moring, 1983). Topical applications of 
4 
isolated crude polysaccharide mixture demonstrated “cortisone like activity,” and 
displayed anti-inflammatory activity in a rat paw oedema model after (Bauer and Wagner, 
1991). Other experiments utilized extracts of roots and herbs of Echinacea purpurea 
have suggested possible effects of the extracts on the environmental matrix of the cells 
active in the healing process, e.g., leukocytes, macrophages, and T-lymphocytes 
(Zoutewelle and van Wijk, 1990). 
In an infection stress test, E. purpurea polysaccharides protected mice infected 
with Candida albicans, and enhanced the survival rate of lethal Candida infections to 100 
percent (R. Bauer, 1998). Caffeic acid derivative echinacoside from the roots of E. 
angustifolia have demonstrated mild antibacterial activity against Staphylococcus aureus 
and Streptococcus pyogenes (Stoll et al, 1950). 
Pentane soluble essential oil extracted from the roots of E. angustifolia and 
pentane extract of E. pallida roots inhibited the growth of Walker carcinosarcoma 256 
and P-388 lymphocyte leukemia in mice (Bauer and Wagner, 1991). The active 
constituent with oncolytic properties has been isolated and identified as (Z)-l,8- 
pentadecadiene, the first diene olefine reported to possess in vivo antitumor activity 
(Voaden and Jacobson, 1972). Treatment of leucopenia patients undergoing radiotherapy 
with a phytopreparation of Echinacea purpurea and Baptisia tinctoria extracts 
significantly increased the number of leukocytes (Wagner, 1995). 
Echinacea species are most known for immunostimulatory activities 
demonstrated in many in vitro experiments, including animal studies and clinical trials. 
Investigation on water and alcoholic extracts of Echinacea species isolated active 
constituents (including lipophilic alkymides and water soluble polysaccharides and 
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cichoric acid). The immunostimulatory activity of Echinacea species is attributed to non¬ 
specific stimulation of the immune system, based on stimulation of phagocytosis and 
activation of lymphocytes, causing increased elimination of pathogenic bacteria, viruses, 
and toxins produced in the bloodstream (Houghton, 1994). 
Significant reduction in viral and bacterial infection susceptibility and 
inflammatory laryngitis was reported in 160 patients suffering from influenza after the 
treatment with E. pallida root extract (Wagner, 1995). In a clinical trial with 32 patients 
with a common cold those treated with E. purpurea root extract preparation recovered 
faster than those in a control group (Scaglione and Lund, 1995). In an in vivo experiment 
with oral administration of ethanolic extracts of Echinacea purpurea, E. angustifolia and 
E. pallida significant stimulation of phagocytosis in mice was reported (Bauer et al, 
1988). The lipophilic fractions of the extracts appeared to be more active than the polar 
fractions (Bauer et al, 1988). 
The polysaccharide arabinogalactan and arabinigalactan-containing glycoproteins 
isolated from roots of Echinacea species have been proven to be responsible for the 
immunostimulating activity. The isolated polysaccharides from all three species 
exhibited a high degree of similarity in immunomodulating and antiviral effects, with the 
E. purpurea extracts exerting the strongest potency (Willigmann et al, 1993; Bodinet et 
al, 1993). Applications of purified polysaccharides from E. purpurea to mice resulted in 
significant protection against the lethal infections with the macrophage-dependent 
Listeria monocytogenes and granulocyte-dependent Candida albicans (Roesler et al, 
1991). 
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According to Stimpel et al (1984), macrophages activated by polysaccharide 
fractions of E. purpurea develop distinctive extracellular cytotoxicity against tumor cells. 
As a result of activation of the macrophages tumor necrosis factor and interferon were 
produced, suggesting therapeutic implications in the defense against tumors and 
infections (Luettig et al, 1989). In other study, purified glycoprotein-containing fractions 
showed indirect antiviral activity against vesicular stomatitis virus via an interferon 
induction, and direct antiviral effect against herpes simplex virus, causing a 100 percent 
plaque-reduction (Bodinet and Beuscher, 1991). 
The study utilizing different models of stomach ulcers in rats revealed strong anti- 
ulcerous effect of the tinctures from fresh flowers and roots of E. purpurea, confirmed by 
clinical studies, and tinctures were recommended as effective remedy for ulcer treatment 
(Voitenko et al, 1995). 
Clinical studies, involving 42 patients with proliferative arthritis, revealed 
significant reduction of clinical symptoms of rheumatoid joint inflammation after the 
treatment with non-steroid antiplogistics in combination with tincture of E. purpurea. 
Immuno-modulating activity of E. purpurea resulted in the increase of both lymphocyte 
content and the number of immunoglobulin of A type. The preparation was 
recommended for complex treatment of proliferative arthritis (Babunina et al, 1994; 
Hryzhak et al,1994). 
Other medicinal plant used as a subject in this investigation, Chenopodium 
ambrosioides L. (Chenopodiaceae) is a native of tropical America but has widely 
established as a weed in gardens, roadsides and waste places in almost all parts of the 
United States. Commonly known as American wormseed, Mexican tea or epazote. 
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Chenopodium ambrosioides is annual erect plant growing 2 to 4 ft. high with yellowish- 
green flowers in spikes, leaves with tiny yellow glands, and dark brown shiny seeds 
(Cronquist and Gleason, 1991). The seeds ripen and are collected in the autumn. The 
whole plant and the essential oil extracted from leaves and seeds are distinguished by 
rank odor, and presently used as fragrance components in creams, lotions, perfumes and 
soaps. Traditionally, the plant was used in cooking as flavoring agent (Duke, 1985). 
Folk uses by native Americans include applying the plant for fevers, headaches, 
rheumatism, swellings, toothaches, stomachaches, bronchitis, and as a tonic. The plant 
was used by rural population in Brazil in the treatment of skin ulceration due to 
Leishmcmia (Viannia) braziliensis (Franca et al, 1996). 
Chenopodium ambrosioides is well known vermifuge. Tea from leaves and 
essential oil distilled from flowering and fruiting plant were widely used to expel 
roundworms, hookworms and intestinal ameba. The plant was considered as the most 
efficient and safe vermifuge, especially for children. The essential oil was officially 
included as an anthelmintic in the U. S. Pharmacopoeia before it was replaced by synthetic 
drugs as a result of difficulties in standardization of the active principle of the drug, and 
toxicity of the oil in high doses (Moerman, 1998; Kay, 1996; Vogel, 1970). Currently, the 
oil of Chenopodium ambrosioides is mainly used in veterinary practice. The plant is 
largely cultivated and oil is distilled in Maryland (Trease and Evans, 1983). 
Recent studies revealed strong toxic effect of Chenopodium ambrosioides against 
Rhizoctonia solani, a plant pathogen responsible for severe damping-off diseases. 
Volatile oil from leaves of Chenopodium exhibited absolute inhibition of the mycelial 
growth of the fungus at 1000 ppm, and at 250 ppm in combination with other volatile oils 
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of Lippia alba and Ocimum canum. At the same time, the oil of Chenopodium did not 
exhibit any adverse effect on seed germination and seedling growth of the experimental 
host plant Phaseolus aureus. Leaves of Chenopodium incorporated with soil were found 
to control damping-off in crop seedlings by 70 percent. Considering antifungal potency 
and lack of phytotoxicity, essential oil of Chenopodium ambrosioides has been observed 
to be superior to several commonly used synthetic fungicides (Dubey and Kishore, 1987; 
Kishore et al, 1989). In other study, the plant exhibited allelopathic effects actually 
inhibiting seed germination and seedling growth of some weeds (Datta and Ghosh, 1987). 
The essential oil of Chenopodium ambrosioides was reported to have absolute 
antifungal activity against nine human pathogenic dermatophytes at a concentration of 50 
ppm (Kishore et al, 1996). Moreover, the oil retained the antidermatophytic activity for 
at least 360 days. 
Crude ethanol extract from seeds of Chenopodium ambrosioides was observed to 
be active against stored grain pests Sitophilis granarius and Tribolium castaneum with 11 
of the most active principles of the extract isolated and identified (Kandil et al, 1989). 
Other studies have confirmed repellent activity of Chenopodium ambrosioides oil against 
stored product insects (Su, 1991; Malik and Nagvi, 1984). Aqueous leaf extract of 
Chenopodium ambrosioides had prevented infection of tobacco mosaic and sunnhemp 
rosette viruses by indirectly increasing the resistance of the host plants, promoting the 
formation of certain virus interfering substances in the host (Verma and Baranwal, 1983). 
Ascaridole, an asymmetric monoterpene endoperoxide with anthelmintic 
properties, is the main constituent (60-80 %) of the essential oil of Chenopodium 
ambrosioides. Naturally occurring endoperoxides from other plants are known for 
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antimalarial activity (Pollack et al, 1990), and in a study undertaken to determine 
antimalarial activity ascaridole was observed to be a potent inhibitor of plasmodial 
growth at low concentrations against Plasmodium falciparum (Pollack et al, 1990). 
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CHAPTER III 
MATERIALS AND METHODS 
Plant material 
Echinacea species {Echinacea purpurea (L.) Moench, E. pallida Nutt., and E. 
angustifolia DC) and Chenopodium amhrosioides L. plants were used in this study. 
Dried roots and herb of Echinacea purpurea, E. pallida and E. angustifolia were obtained 
from Trout Lake Farm (Trout Lake, WA). Additional Echinacea plants and 
Chenopodium amhrosioides were grown from seed (Richters, Ontario, Canada) in a 
greenhouse at the Department Plant and Soil Sciences, University of Massachusetts at 
Amherst, MA (42.2 0 North latitude) with full sunlight with a day temperature range of 
23.0 - 35.0 °C, depending on outside temperatures, and a minimum night temperature of 
19 °C. The seeds of the plants grown in the greenhouse were sown in a commercial 
potting mixture, ProMix BX (peat moss:vermiculite:perlite, 60:20:20 parts by volume, 
pH 6.0), contained in plastic pots (4.0 cm in diameter). At the seedling stage, fresh plants 
were transferred to larger plastic pots (22.5 cm in diameter). To maintain vigorous 
growth, plants were fertilized with 100 ml solution of Peat-Lite Special® with 
concentration of nitrogen at 350 ppm. Plants were harvested at flowering and fruiting 
stage (15 weeks after sowing for Chenopodium amhrosioides plants and 36 - 40 weeks 
after sowing for Echinacea plants) and the roots and tops separated from each other. The 
essential oil was immediately extracted from the fresh tissues, including stems, leaves, 
flowers, and seeds for Chenopodium amhrosioides, and roots, stems, leaves, and flowers 
for Echinacea plants (Fig. 1-7). 
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Extraction 
Extraction of essential oils was done by simultaneous steam distillation-solvent 
extraction (Likens and Nickerson, 1964, Koedam et al, 1979; Godefroot et al, 1981) (Fig. 
8). Plant material (50 g) was transferred to a 500 ml distillation flask containing 250 ml 
of distilled water. The solvent n-pentane (25 ml) was added to 50 ml round-bottomed, 
receiving flask. Before starting the extraction, 2.5 ml of distilled water and 2 ml of n- 
pentane were introduced into the return arm of the unit. The reflux of pentane and plant 
material was started by heating the flasks at 50 °C and 100 °C, respectively, for smooth 
boiling in the sample and the solvent flasks. The vapors were captured in condensers 
with circulating ice-cold water above the unit. Condensed distillate and solvent dripped 
to U-tube of the return arm with separation of the two phases and return to respective 
flasks, resulting in all volatile material being collected in the solvent containing flask. At 
the end of the distillation procedure (one hour for Echinacea spp. and 30 minutes for 
Chenopodium ambrosioides), the n-pentane was removed from the distillate by rotary 
vacuum evaporation at 40 °C and under a nitrogen atmosphere. Essential oil samples 
were maintained under 5 °C until tested for antimicrobial activity. 
Test microorganisms 
Gram-positive Staphylococcus aureus (ATCC 25923) and Enterococcus faecalis 
(ATCC 19433), Gram-negative Escherichia coli (ATCC 25922) and Pseudomonas 
aeruginosa (ATCC 27853), and the yeast Candida albicans (ATCC 14053) were used as 
test organisms. Cultures of each test organism were maintained in tryptic soy broth (for 
bacteria) and potato dextrose broth (for yeast). 
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Experimental 
Antimicrobial activity of essential oils was evaluated using an agar diffusion test 
(Barry, 1976; Janssen et al, 1986). To prepare for the diffusion test, an inoculating loop 
full of each bacterium and the yeast culture was used to inoculate individual tube slants of 
tryptic soy agar (for bacteria) and potato dextrose agar (for the yeast) for overnight 
incubation at 37 °C. A suspension of each bacteria and yeast from the 24 h slant was 
subsequently prepared in sterile saline solution to obtain a turbidity equal to a McFarland 
standard 0.5 (108 CFU/ml) prior inoculation. 
The prepared suspension of each microbe was inoculated by streaking on the 
surface of Mueller-Hinton agar contained in Petri plates (9 cm in diameter). A sterile 
filter paper disc (BBLK 0.6 cm in diameter) was placed on the agar surface. The essential 
oil, (5 pi of selected undiluted oil), was pipetted on the paper disc on the agar surface. 
An antibiotic containing disc (Vancomycin, Polymixin B, or Nystatin, depending on the 
microorganism) served as a positive control on the same plate, and a third disc 
impregnated with 5 pi of sterile distilled water (to serve as a negative control) was placed 
on the same plate. The three discs on each plate were equidistant from each other. After 
placement of the discs, the plates were inverted and incubated overnight at 37 °C. 
Antimicrobial activity was determined by measuring the diameter of the clear zone 
around each disc. All assays were done in triplicate. 
Statistical analysis 
Data were analyzed using analysis of variance with Duncan's New Multiple- 
Range test used for separation of means. 
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CHAPTER IV 
RESULTS 
Essential oil 
The essential oil obtained from fresh herb of Chenopodium ambrosioides (2.6 % 
fresh weight) was colorless with a strong camphoraceous aroma (Table 2). The essential 
oils obtained from fresh herb and roots of Echinacea species (average of 0.05 %) were a 
light yellow color with a pleasant aroma. Fresh Echinacea purpurea herb contained the 
highest concentration of essential oil (0.2 % fresh weight). Fresh roots of Echinacea 
pallida contained a higher concentration of essential oil than roots from the other 
Echinacea species (0.08% fresh weight). Dried Echinacea purpurea herb had an 
essential oil concentration of 0.1 percent, a level lower than that of fresh herb. Dried 
roots of Echinacea pallida also contained a lower concentration of essential oil (0.07 %) 
than fresh roots of this species. Tissue from Echinacea angustifolia roots and herb had 
the lowest essential oil concentrations among the tested Echinacea species. 
Antimicrobial activity 
The essential oil from fresh herb of Chenopodium ambrosioides demonstrated 
antimicrobial activity only against yeast (Table 3), but in comparison with the antibiotic 
nystatin was relatively ineffective in preventing growth of the yeast organism. In 
contrast, the essential oil from fresh and dried tissues of Echinacea species demonstrated 
significant antimicrobial activity against all microorganisms tested. 
The essential oil from dried roots of Echinacea purpurea and E. angustifolia 
significantly inhibited the growth of gram-negative E. coli, superior to that exhibited by 
the antibiotic Polymixin B. Essential oils from dried roots of Echinacea purpurea and E. 
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angustifolia also inhibited the growth of the gram-negative P. aeruginosa, but the growth 
inhibition was less than that exhibited by the antibiotic Polymixin B. In contrast, the 
essential oils extracted from dried herb of the Echinacea species were more effective 
against P. aeruginosa than against E. coli. The essential oils from fresh roots tissue of 
Echinacea species demonstrated no inhibition of gram-negative bacteria. The essential 
oil from fresh herb of Echinacea purpurea inhibited the growth of P. aeruginosa only. 
Essential oils from dried roots of Echinacea species were also active against the 
gram-positive S. aureus. The essential oil from dried roots of Echinacea purpurea 
inhibited the growth of S. aureus more than the essential oil from dried roots and herb of 
E. pallida and E. angustifolia. Essential oils extracted from fresh roots of Echinacea 
were less active against S. aureus than essential oils from dried roots. Only essential oil 
from fresh root of Echinacea pallida demonstrated antimicrobial activity against gram¬ 
positive Enterococcus faecalis. 
The essential oils from dried herb of Echinacea species also inhibited the growth 
of S. aureus. The essential oil from dried herb of Echinacea pallida was more active than 
essential oils of dried herb of E. pallida and E. angustifolia. The essential oils from fresh 
herb of Echinacea species demonstrated less activity against S. aureus, but inhibited the 
growth of Enterococcus faecalis. 
The essential oils extracted from Echinacea species had antimicrobial activity 
against the yeast Candida albicans with the level of inhibition superior to that of the 
antibiotic nystatin. Essential oils from dried roots of Echinacea angustifolia and E. 
purpurea exhibited the highest activity. In contrast, the essential oil from dried herb of 
Echinacea pallida inhibited the growth of Candida albicans more than essential oils from 
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dried herbs of E. angustifolia and E. purpurea. The essential oil from fresh herb of E. 
angustifolia inhibited the yeast organism more than essential oils from fresh herb of E. 
pallida and E. purpurea. 
Overall, essential oils extracted from dried roots and herb tissue of Echinacea 
species had higher antimicrobial activity than essential oils extracted from fresh roots and 
herb tissue. In contrast, only essential oils extracted from fresh roots and herb tissue of 
Echinacea species inhibited the growth of the gram-positive bacterium Enterococcus 
faecal is. 
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CHAPTER V 
DISSCUSION 
Essential oil 
Chenopodium ambrosioides was previously reported to contain 0.4-1 percent of 
essential oil obtained from fresh herb, and 1-4 percent of essential oil obtained from seeds 
(Trease and Evans, 1983). According to Sagrero-Nieves and Bartley (1995), fresh leaves 
of Chenopodium ambrosioides yielded 1.2 percent of essential oil. In our study, fresh 
herb and seeds of Chenopodium ambrosioides were used for distillation of an essential 
oil, and the results obtained (2.6 percent of essential oil) confirm previous reports. 
Analysis of essential oil content of Echinacea species by Bauer and Wagner 
(1991) showed that Echinacea species contain various amounts of the essential oil, with 
less than 0.1 percent of essential oil reported for E. angustifolia, and 0.01-0.6 percent of 
essential oil reported for E. pallida and E. purpurea. In our study, the least amount of an 
essential oil was also obtained from fresh and dried tissue of Echinacea angustifolia, and 
the highest amount of an essential oil was obtained from fresh herb (including flowers) of 
E. purpurea and from fresh roots of E. pallida. Minimal differences in essential oil yield 
of dried and fresh tissues observed in this study, where dried tissues of Echinacea species 
yielded same or higher amount of essential oil than fresh tissues, are probably due to high 
content of moisture in fresh tissues, contributing to the overall weight. 
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Antimicrobial activity 
Antifungal activity of Chenopodium ambrosioides essential oil against the 
pathogenic yeast Candida albicans supports the broad antifungal activity of the plant 
previously reported against plant and human pathogenic fungi (N. Kishore et al, 1989; N. 
Kishore et al, 1996). Candida albicans, as a dimorphic fungus, is able to grow in the 
yeast and mycelium forms, depending on environmental conditions. As human and 
animal pathogen, Candida albicans often occurs in systemic infections in the mycelial 
form, which resist phagocytosis (Saltarelli, 1989). Total inhibition of the growth of other 
yeast species Candida utilis, C. tropicalis and C. lipolytica by essential oils of Origanum 
species was reported previously (Charai, 1996). According to Adams et al (1996), 
significant inhibition of fungal mycelia and deformation of fungal cell wall composition 
of the common food contaminating fungus have been observed after treatment with some 
essential oil components. 
Antifungal action of the essential oil of Chenopodium ambrosioides has been 
attributed to ascaridol, the unsaturated monoterpene peroxide, which constitutes about 70 
to 90 percent of the essential oil (Duke, 1985; Williamson and Evans, 1988). In contrast, 
limonene and trans-pinocarveol were identified as major compounds of the oil of 
Chenopodium ambrosioides growing in Mexico, comprising respectively 32.5 and 26.7 
percent of the total oil (Sagrero-Nieves and J. P. Bartley, 1995). In my opinion, lack of 
detectable amounts of ascaridol reported by the authors above is due to the long (3 hours) 
steam distillation procedure used for the extraction of the essential oil. Ascaridol was 
reported to gradually decompose while boiling with water, and rapid distillation 
procedures have been suggested (Trease and Evans, 1983). 
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Lack of antibacterial activity of the oil of Chenopodium ambrosioides against 
gram-positive and gram-negative microorganisms in this study is probably due to lack of 
phenolic and alcoholic compounds in the oil, compounds that are reported to be 
responsible for the antibacterial activity of essential oils (Knobloch et al, 1986). 
According to Kishore et al (1996), no detectable phenols were observed in essential oil of 
Chenopodium ambrosioides. Additional studies will be needed to evaluate the chemical 
composition of the essential oil of Chenopodium ambrosioides in reference to the 
biological activity. 
Significant antifungal activity of Echinacea essential oils against Candida 
albicans exerted in this study suggest conducting more detailed investigations in the 
future considering importance of the microorganism as human opportunistic pathogen. 
Clinical studies have previously demonstrated the efficacy of the extracts of Echinacea 
species against recurrence of vaginal candidiasis (Houghton, 1994). The results of this 
study also suggest additional investigations of the potential antifungal activity of 
Echinacea essential oils against other human and plant pathogenic fungi. 
In our study, gram-negative bacteria used as the test microorganisms were more 
resistant to the essential oils of Echinacea than gram-positive. Different sensitivity of 
gram-negative and gram-positive bacteria may be due to differences in cell wall structure 
with an additional outer lipid bilayer membrane around gram-negative bacteria cell wall, 
although being lipid soluble essential oil compounds would be expected to easily 
penetrate through the cell wall. According to Knobloch et al (1986), the site of 
antimicrobial action of essential oil compounds occurs within the bacterial cytoplasm 
respiratory system, where functional groups of essential oil compounds can successfully 
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interfere with the process of energy metabolism. Based on our results, the growth of 
gram-positive Enterococcus faecalis was inhibited only by essential oils extracted from 
fresh tissues of Echinacea species. Structural specificity of Enterococcus faecalis as 
group D streptococcus (Sneath et al, 1986) probably makes the microorganism more 
sensitive to chemical constituents of essential oils extracted from fresh tissues. 
The essential oils from aerial parts of Echinacea species are reported to contain 
borneol, bornyl acetate, polyacetylenes, germacrene D, caryophyllene, caryophyllene 
epoxide and palmitic acid (Bauer and Wagner, 1991). In addition, the achenes of 
Echinacea species are reported to contain a-pinene, p-pinene, myrcene, p-fernesene and 
limonene (Bauer and Wagner, 1991). Polyacetylenes in the essential oils isolated from 
Echinacea purpurea and E. angustifolia roots have previously demonstrated 
bacteriostatic activity against Escherichia coli and Pseudomonas aeruginosa (Bauer and 
Wagner, 1991). The antimicrobial properties of various essential oils constituents have 
been previously reported (Cruz et al, 1993; Deans, 1991). According to Chalchat and 
Garry (1997), certain patterns linking the composition and antimicrobial activity of the 
essential oils have been noted, where African essential oils, containing a-pinene, p- 
pinene, myrcene, limonene, germacrene D and caryophyllene as major constituents, 
display antimicrobial activity against six microbial strains, including gram-positive 
Staphylococcus aureus, gram-negative Escherichia coli and Pseudomonas aeruginosa, 
and Candida albicans. The present study suggests more detailed investigations are 
necessary to evaluate the active principles of essential oils of Echinacea species 
possessing antimicrobial properties. 
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Significant differences in antimicrobial activity between essential oils extracted 
from dried and fresh tissues of Echinacea species observed in this study are probably due 
to chemical decomposition of the essential oil compounds during drying procedure and 
long term storage of the plant material. According to Bauer and Wagner (1991), detailed 
investigations on essential oil compounds demonstrated that artifacts were produced by 
autoxidation of the native constituents in stored roots of E. pallida. No detectable 
polyacetylenes were observed in fragmented root material of E. augustifolia after long 
term storage. Germacrene alcohol, a component of essential oil from fresh aerial parts of 
E. purpurea, has not been detected in dried tissues. 
In this study, any chemical decomposition of Echinacea essential oil constituents 
favored microbial inhibition properties, as oils extracted from dried plant tissues had 
higher antimicrobial activity than oils extracted from fresh plant tissues. Additional 
studies will be needed to evaluate qualitative differences in essential oil composition of 
dried and fresh tissues of Echinacea species. 
Significant antimicrobial properties of essential oils isolated from Echinacea 
species in the present study support traditional uses of the plant by Native Americans in 
septic conditions, sore throats and skin inflammations, associated with bacterial 
infections. 
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Table 1. Echinacea species of medical importance. 
Specie Botanical characteristics Distribution 
Echinacea purpurea 
(L.) Moench 
Perennial, 2-5 feet high, 
stems rough-bristly, leaves 
rough, coarsely toothed, 
lowest leaves ovale, veiny, 
long-petioled, upper leaves 
oval-lanceolate, ray flowers 
rose to deep purple, pales with 
bright orange tips, fibrous roots. 
Flowers June-October 
Dry open woods, prairies. 
Iowa, Illinois, Michigan, 
Ohio and Virginia, south 
to Oklahoma, Georgia and 
Louisiana. 
E. angustifolia DC. Perennial 5-20 inches high, 
stems rough-bristly, leaves 
lanceolate, entire, 3-nerved, 
ray flowers purple, very short, 
spreading, tap root. 
Flowers May-August 
Prairies and barrens. 
Minnesota, Saskatchewan, 
south to Oklahoma, Texas. 
E. pallida Nutt. Perennial 5-40 inches high, 
stems with slender hairs, leaves 
lanceolate, ray flowers strongly 
drooping, curving toward the 
stem, pink to purple, white 
pollen, tap root. 
Flowers June-July 
Prairies and barrens. 
Michigan to Nebraska, 
south to Alabama, Texas, 
Louisiana. 
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Table 2. Essential oil yields. 
Plant Plant part1 Essential oil yield 
(% of fresh or dried sample)2 
Echinacea pallida fresh herb3 0.02 
fresh root 0.08 
dried herb 0.05 
dried root 0.07 
E. purpurea fresh herb 0.20 
fresh root 0.02 
dried herb 0.10 
dried root 0.02 
E. angustifolia fresh herb 0.01 
fresh root 0.01 
dried herb 0.05 
Chenopodium 
dried root 0.02 
ambrosioides fresh herb 2.60 
1 Fresh and dried material come from different sources and cannot be directly compared. 
2 Differences in concentration of essential oil in fresh material as compared with dried 
material probably result from differences in plant source; differences are consistent with 
other reports (Bauer and Wagner, 1991). 
3 Herb defines the aboveground part, including stems, leaves, and flowers. 
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Table 3. Antimicrobial activity of essential oils. 
Essential oil (5 pi) Microorganisms 
S. aureus E. faecal is E. coli P. aeruginosa C. albicans 
Echinacea pallida 
dried roots 13.0' abc _3 8.5 c - 14.5 fg 
fresh roots 10.5 be 13.5 ab - - 22.0 def 
dried herb 15.5 a - 7.5 c 11.5b 41.5b 
fresh herb 10.5 be 9.5 b - - 24.5 ede 
E. purpurea 
dried roots 15.5 a - 25.5 a 14.5 a 45.0 ab 
fresh roots 9.5 c - - - 15.5 efg 
dried herb 14.5 ab - • 8.5 c 17.0 efg 
fresh herb 11.5 abc 14.0 a - 8.5 c 13.5 fg 
E. angustifolia 
dried roots 11.0 abc - 18.0 b 14.5 a 52.0 a 
fresh root - - - - 10.0 g 
dried herb 14.5 ab — 8.5 c 31.0c 
fresh herb 10.5 be 9.5 b - - 29.5 cd 
C. amhrosioides 
fresh herb - - - - 21.5 def 
Positive control 20.0 20.0 15.0 15.0 25.0 
Vancomycin 30 meg Polymyxin B 300 Units Nystatin 100 Units 
Negative control 
(distilled water) - - - - - 
1 Mean of 3 replications; means with the same letter within the column are not 
significantly different by Duncan’s New Multiple Range Test (p<0.05). 
2 Includes diameter of the paper disc (6 mm). 
3 No inhibition of microbial growth. 
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Figure 1. Chenopodium ambrosioides L. 
25 
Figure 2. Echinacea pallida Nutt. 
26 
Figure 3. Echinacea purpurea (L.) Moench 
27 
S' «
 
Figure 4. Echinacea angustifolia DC. 
28 
Figure 5. Echinacea pallida roots. 
29 
Figure 6. Echinacea purpurea roots. 
30 
Figure 7. Echinacea angustifolia roots. 
31 
Figure 8. Simultaneous steam distillation-solvent extraction unit. 
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